1-(3-METHYLPHENYL)CYCLOBUTAN-1-AMINE HCL, 95.0%, 250mg

(8-syn)-3-Azabicyclo[3.2.1]octan-8-ol hydrochloride, 95.0%, 100mg

1-(4-METHYLPYRIDIN-2-YL)ETHANOL, 95.0%, 250mg

2-[3,5-dimethyl-1-(2,2,2-trifluoroethyl)-1h-pyrazol-4-yl]acetic acid, 95%, 1g

5-Bromo-3-iodo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole, 97%, 5g

6-Isopropyl-7-oxo-5-phenyl-4,7-dihydropyrazolo[1,5-a]pyrimidine-3-carbonitrile, 97.0%, 25mg

2-(4-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperazin-1-yl)acetic acid, 95.0%, 25g

4-Methylbenzotrifluoride, 98.0%, 1g

4,4'-Dimethoxydiphenylamine>98.0%(GC)(T)1g

2-Methylamino-1-morpholin-4-yl-ethanonehydrochloride, 98.0%, 1g

6-Chloro-3-methyl-[1,2,4]triazolo[4,3-b]pyridazine, 95.0%, 1g

D-(+)-Raffinose Pentahydrate>98.0%(HPLC)25g

GC capillary column ROTI®Cap-1, 20 m, 0.10 mm, 0.40 µm, 1 Piece(s)